These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9250542)

  • 21. [Severe heart failure. Carvedilol lowers mortality].
    MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
    [No Abstract]   [Full Text] [Related]  

  • 22. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.
    Fraga R; Franco FG; Roveda F; de Matos LN; Braga AM; Rondon MU; Rotta DR; Brum PC; Barretto AC; Middlekauff HR; Negrão CE
    Eur J Heart Fail; 2007; 9(6-7):630-6. PubMed ID: 17475552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysis.
    Takekuma Y; Takenaka T; Kiyokawa M; Yamazaki K; Okamoto H; Kitabatake A; Tsutsui H; Sugawara M
    Biol Pharm Bull; 2007 Mar; 30(3):537-42. PubMed ID: 17329852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-blockade and amiodarone therapy: twin brothers from different parents.
    Eichhorn EJ; Hamdan MH
    J Card Fail; 1998 Dec; 4(4):289-94. PubMed ID: 9924850
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.
    Horiuchi I; Nozawa T; Fujii N; Inoue H; Honda M; Shimizu T; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2008 May; 31(5):976-80. PubMed ID: 18451529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 28. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
    J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree?
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546
    [No Abstract]   [Full Text] [Related]  

  • 31. Carvedilol therapy in heart failure--III.
    Lee YC
    J Am Coll Cardiol; 1995 Nov; 26(5):1400-1. PubMed ID: 7594061
    [No Abstract]   [Full Text] [Related]  

  • 32. Now there are four: Carvedilol takes its place in therapeutical line-up for heart failure.
    Phillips L
    Hosp Technol Ser; 1997 Mar; 16(3):6-7. PubMed ID: 10166705
    [No Abstract]   [Full Text] [Related]  

  • 33. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
    Horenstein MS; Ross RD; Singh TP; Epstein ML
    Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current research on carvedilol in heart failure.
    Bobadilla RV
    Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050
    [No Abstract]   [Full Text] [Related]  

  • 35. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 36. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb; 145(8):57. PubMed ID: 12661451
    [No Abstract]   [Full Text] [Related]  

  • 37. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 38. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 39. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 40. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.